Literature DB >> 17126343

Serum C-reactive protein response to percutaneous coronary intervention in patients with unstable or stable angina pectoris is associated with the risk of clinical restenosis.

Nawsad Saleh1, Per Tornvall.   

Abstract

BACKGROUND: Inflammation plays a pivotal role in the pathogenesis of atherosclerosis. Previous reports have used vaccination as a model to stimulate inflammation. The aim of the present study was to investigate the role of C-reactive protein response to PCI in the risk of clinical restenosis or new coronary stenosis, considering PCI as a model to stimulate inflammation.
MATERIAL AND METHODS: Eight hundred and ninety-one patients with stable or unstable angina pectoris and with normal serum troponin T<or=0.03 microg/L before PCI were investigated. The survivors after a follow-up period of 2.6 years (850 patients) were included. Serum CRP and troponin T concentration were measured before and the day after PCI. Restenosis and new coronary stenosis, detected by coronary angiography due to symptomatic coronary heart disease, were determined.
RESULTS: CRP response to PCI, unstable angina pectoris, the number of vessels dilated and lack of stent implantation were associated with restenosis or new coronary stenosis. In multivariate analysis, patients in the highest tertile of CRP, induced by PCI, had an increased risk (risk ratio 1.7 [95% CI 1.1-2.9]) for restenosis or new coronary stenosis. Furthermore, patients with restenosis had an increased CRP response to PCI compared with those with new coronary stenosis.
CONCLUSION: The CRP response to PCI, as a model to stimulate inflammation, is associated with an increased risk of clinical restenosis. The results emphasize the role of CRP in the pathogenesis of coronary artery disease progression and in particular restenosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17126343     DOI: 10.1016/j.atherosclerosis.2006.10.026

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  8 in total

1.  Inflammatory response to percutaneous coronary intervention in stable coronary artery disease.

Authors:  Peter S Munk; Unni M Breland; Pål Aukrust; Oyvind Skadberg; Thor Ueland; Alf I Larsen
Journal:  J Thromb Thrombolysis       Date:  2011-01       Impact factor: 2.300

Review 2.  Impact of C-reactive protein on in-stent restenosis: a meta-analysis.

Authors:  Jian-Jun Li; Yi Ren; Ke-Ji Chen; Alan C Yeung; Bo Xu; Xin-Min Ruan; Yue-Jin Yang; Ji-Lin Chen; Run-Lin Gao
Journal:  Tex Heart Inst J       Date:  2010

3.  Thirty-day vein remodeling is predictive of midterm graft patency after lower extremity bypass.

Authors:  Warren J Gasper; Christopher D Owens; Ji Min Kim; Nancy Hills; Michael Belkin; Mark A Creager; Michael S Conte
Journal:  J Vasc Surg       Date:  2012-09-07       Impact factor: 4.268

4.  Angiotensin type 1 receptor A1166C gene polymorphism is associated with endothelial dysfunction and in-stent restenosis after percutaneous coronary intervention.

Authors:  Yu Li; Fang Chen; Xiaoling Zhang; Yuechun Gao; Changyan Wu; Haiyan Li; Yuchen Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

5.  Impact of Exercise-based Cardiac Rehabilitation on In-stent Restenosis with Different Generations of Drug Eluting Stent.

Authors:  Chul Kim; Hee Eun Choi; Byung Ok Kim; Min Ho Lim
Journal:  Ann Rehabil Med       Date:  2012-04-30

6.  Impact of exercise-based cardiac rehabilitation on de novo coronary lesion in patients with drug eluting stent.

Authors:  Hee Eun Choi; Byeong Ju Lee; Chul Kim
Journal:  Ann Rehabil Med       Date:  2014-04-29

7.  Coronary revascularisation in stable patients after an acute coronary syndrome: a propensity analysis of early invasive versus conservative management in a register-based cohort study.

Authors:  Raffaele Bugiardini; Markku Eskola; Heini Huhtala; Kari Niemelä; Pekka Karhunen; Rossella Miglio; Olivia Manfrini; Carmine Pizzi; Kjell Nikus
Journal:  BMJ Open       Date:  2013-04-24       Impact factor: 2.692

8.  Association of a common TLR-6 polymorphism with coronary artery disease - implications for healthy ageing?

Authors:  Lutz Hamann; Alexander Koch; Saubashya Sur; Nadja Hoefer; Christiane Glaeser; Susanne Schulz; Michael Gross; Andre Franke; Ute Nöthlings; Kai Zacharowski; Ralf R Schumann
Journal:  Immun Ageing       Date:  2013-10-30       Impact factor: 6.400

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.